. Author manuscript; available in PMC: 2010 Oct 28.

Published in final edited form as: Psychol Addict Behav. 2006 Sep;20(3):241–253. doi: 10.1037/0893-164X.20.3.241

Table 4.

Significant standardized and unstandardized path coefficients with their associated effect sizes between mediators in the final PDA and DDD models

	PDA			DDD
Path	Unstd Estimates	Std^a Estimates	ES	Unstd Estimates	Std^a Estimates	ES
Treatment Compliance
Self-Efficacy (mo 0)	.065	.055, .061	S	.061	.052, .057	S
PDA/DDD (mo 0)	n.s.	n.s.		−.007	−.061, −.079	S
AAI (mo 0)	−.136	−.060, −.050	S	n.s.	n.s.
Impairment (mo 0)	−.065	−.054, −.058	S	−.058	−.049, −.052	S
Self-Efficacy (mo 3)
Compliance	.213	.209, .220	S	.210	.210, .223	S
Self-Efficacy (mo 0)	.298	.246, .289	M	.294	.243, .285	S, M ^a
Impairment (mo 0)	−.12	−.099, −.112	S	−.122	−.101, −.114	S
Self-Efficacy (mo 9)
Self-Efficacy (mo 3)	.353	.312, .314	M	.396	.350, .349	M
AAI (mo 9)	n.s.	n.s.		.034	.050, .054	S
vPDA/DDD (mo 9)	.434	.311, .294	M	−.045	−.216, −.256	S
Impairment (mo 0)	−.158	−.115, −.131	S	−.143	−.104, −.118	S
AA Involvement (mo 4−9)
Self-Efficacy (mo 3)	.228	.137, .126	S	.228	.137, .126	S
AAI (mo 0)	1.773	.459, .371	M, L	1.778	.460, .372	M, L
Impairment (mo 0)	.126	.063, .065	S	.122	.060, .063	S
AA Involvement (mo 10−15)
AAI (mo 9)	.800	.753, .761	L	.800	.753, .762	L
PDA (mo 4−9)
Compliance	.140	.170, .190	S	−1.024	−.186, −.166	S
Self-Efficacy (mo 3)	.249	.307, .327	M	−1.522	−.283, −.239	S, M ^a
AAI (mo 9)	.100	.206, .238	S	−.358	−.111, −.102	S
PDA/DDD (mo 0)	.207	.205, .206	S	.178	.275, .320	M
PDA/DDD (mo 10−15)
Self-Efficacy (mo 9)	.073	.094, .098	S	−.782	−.166, −.134	S
AAI (mo 9)	−.032	−.061, −.069	S	n.s.	n.s.
AAI (mo 15)	.094	.187, .211	S	−.250	−.083, −.072	S
PDA/DDD (mo 9)	.789	.723, .714	L	.655	.660, .630	L

PDA = Percent Days Abstinent, DDD= Drinks per Drinking Day, Unstd = Unstandardized path coefficients, Std = Standardized path coefficients, ES = Effect size, n.s. = not significant

(Outpatient, Aftercare)